Technology Opportunities

A test method based on a genetic polymorphism in the Haptoglobin gene identifies those individuals with Diabetes who are at high risk for developing heart, eye and kidney disease and who benefit from specific drug treatments, has been validated in multiple clinical trials worldwide. Diabetes is ...

Optogenetics approaches, utilizing light-sensitive proteins, have emerged as unique experimental paradigms to modulate neuronal excitability and have consequentially revolutionized neuroscience. The group of Dr. Lior Gepstein is developing similar strategies to also control cardiac-tissue ...